"Chulalongkorn University"

Chula’s Pharmaceutical Science Has Developed a User-friendly and Rapid Test Kit to Keep People Away from COVID-19.

The ChulaCov-19 mRNA vaccine is now entering its phase 3 trial in Thailand, the Vaccine Research Centre, Faculty of Medicine, Chulalongkorn University, announced on Thursday.

A Chula research team has developed a screening strip kit to detect the early stage of chronic kidney disease (CKD) that’s easy to use, yields quick results, increasing the chance of being cured for patients, and helping to cut over 10 billion baht of the ever-increasing annual healthcare costs for CKD patients.

Student councils from across the country issued a statement on Thursday rejecting the Constitutional Court’s ruling that pro-democracy leaders Arnon Nampa, Panupong “Mike” Jadnok and Panassaya “Rung” Sitthichirawatanakul aimed to overthrow the government.

First time in Thailand! Chula’s “Roadmap and Life Tools for the New Generation”, a world-class program accredited by Stanford University, is ready to be offered to teach students the needed skills to design their life and the mindset for working with others so that they can build the future and society.

Covid-19 patients are being advised to avoid contact with their pets after a local study found that dogs and cats can contract the virus from their infected owners.

Faculty members of Chula’s Faculty of Education collaborate with academicians from four academic institutions to research the future of “Hua Lamphong” as a creative space to preserve the history and culture linking the old town and the new commercial district, after the railway hub moved to Bang Sue Central Station.

The Cabinet has approved a budget of THB2.3 billion for phase 3 clinical testing and production of the ChulaCov19 mRNA vaccine, deputy government spokesperson Ratchada Thanadirek said on Thursday.

A professor from Chulalongkorn University’s Faculty of Commerce and Accountancy is warning entrepreneurs of the “3Ps” they should avoid and to hang on to hope that this fourth wave of Covid-19 will soon pass.

Chulalongkorn University researchers have launched the second human trial of Chula-Cov19 mRNA vaccine, after the Phase 1 trial greatly boosted volunteers’ antibodies against the Covid virus.

Thai researchers have tapped the abilities of sniffer dogs to create what is thought to be the world’s first sweat test for Covid-19.

Clinical trials for the Thai “ChulaCov19” mRNA vaccine have been a success as healthy volunteers to whom it was administered are found to have good immunity after they have been vaccinated.